Jefferies Starts Allergen (AGN) at Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Wall St inches up on megacap strength; Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil slides on clues about Fed policy, rumors of Hormuz deal
- Dollar rises to session high after Warsh comments, set for weekly gain
- First Financial to acquire Hickory Point Bank in $111.3M deal
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- BioNTech ends colorectal cancer mRNA therapy trial early
- Ovintiv adds 41,000 acres in Permian and Montney deals
Edward Jones Downgrades Allergen (AGN) to Sell
April 23, 2014 2:06 PM EDTEdward Jones downgraded Allergen (NYSE: AGN) from Hold to Sell.
For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.
Shares of Allergen closed at $163.65 yesterday.
... MoreJPMorgan Upgrades Allergen (AGN) to Overweight
April 23, 2014 6:35 AM EDTJPMorgan upgraded Allergen (NYSE: AGN) from Neutral to Overweight with a price target of $190.00 (from $130.00).
For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.
Shares of Allergen closed at $163.65 yesterday.
... MoreArgus Downgrades Allergen (AGN) to Hold
April 22, 2014 2:56 PM EDTArgus downgraded Allergen (NYSE: AGN) from Buy to Hold with a price target of $130.00 (unchanged).
For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.
Shares of Allergen closed at $142.00 yesterday.
... MoreAllergan (AGN) Plans to Carefully Review Valeant (VRX) Offer
April 22, 2014 11:06 AM EDTAllergan, Inc. (NYSE: AGN) today confirmed that it has received an unsolicited proposal from Valeant Pharmaceuticals International, Inc. (NYSE: VRX) to acquire all of the outstanding shares of the Company for a combination of 0.83 of Valeant... More
Pharma M&A May be Entering Megadeals Phase, Says Goldman Sachs Analyst (AGN) (VRX) (PFE) (AZN) (ACT) (FRX)
April 22, 2014 8:44 AM EDTValeant Pharmaceuticals International, Inc. (NYSE: VRX) announced Tuesday that it has submitted a merger proposal to the Board of Directors of Allergan, Inc. (NYSE: AGN) under which each Allergan share would be exchanged for $48.30 in cash and 0.83 shares of... More
Valeant (VRX) Enters Cash, Stock Bid for Allergan (AGN)
April 22, 2014 7:34 AM EDTValeant Pharmaceuticals International, Inc. (NYSE: VRX) announced that it has submitted a merger proposal to the Board of Directors of Allergan, Inc. (NYSE: AGN) under which each Allergan share would be exchanged for $48.30 in cash and 0.83 shares of Valeant common stock, based on the fully diluted number of Allergan shares outstanding. Shareholders will be able to elect a mix of cash and shares, subject to proration. The proposal represents a substantial premium based on Allergan's unaffected price of $116.63 on April 10, 2014, the day before Pershing Square Capital Management L.P.... More
